The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?

This publication has 13 references indexed in Scilit:

• Keynote address: Concepts and developments in radiosensitization of mammalian cells
  International Journal of Radiation Oncology*Biology*Physics, 1992
• The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins
  International Journal of Radiation Oncology*Biology*Physics, 1992
• DT-diaphorase and cancer chemotherapy
  Biochemical Pharmacology, 1992
• The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09
  Cancer Communications, 1991
• Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual
  Biochemical Pharmacology, 1991
• In vitro and in vivo evaluation of the indoloquinone EO-9 (NSC 382 459) against human small cell carcinoma of the lung
  European Journal of Cancer and Clinical Oncology, 1989
• Increased sensitivity of quinone resistant cells to mitomycin C
  Cancer Letters, 1989
• Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions
  British Journal of Cancer, 1989
• The nitroreductase enzyme in walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)
  Biochemical Pharmacology, 1988
• Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
  Journal of Immunological Methods, 1983